The agency updated its list of recommended influenza virus strains that manufacturers should include in vaccines for the autumn 2018 season.
On April 30, 2018, the European Medicines Agency (EMA) updated the European Union list of recommendations for influenza virus strains that manufacturers should include in vaccines for the autumn 2018 season. The update contains a decision on suitable strains for live, attenuated vaccines. EMA also updated the list of reagents for vaccine standardization.
The ad-hoc Influenza Working Group initially made recommendations for the 2018/2019 flu vaccines on March 26, 2018. The list is developed on the basis of recommendations by the World Health Organization.
Applications to change the composition of centrally authorized flu vaccines are due by June 18, 2018.
Source: EMA
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.